Prevention and Management of Dermatologic Adverse Events Associated With Tumor Treating Fields in Patients With Glioblastoma

Importance: Tumor Treating Fields (TTFields) are an anti-mitotic treatment approved for treating newly diagnosed and recurrent glioblastoma, and mesothelioma. TTFields in glioblastoma comprise alternating electric fields (200 kHz) delivered continuously, ideally for ≥18 h/day, to the tumor bed via t...

詳細記述

書誌詳細

出版年:	Frontiers in Oncology
主要な著者:	Mario E. Lacouture, Milan J. Anadkat, Matthew T. Ballo, Fabio Iwamoto, Suriya A. Jeyapalan, Renato V. La Rocca, Margaret Schwartz, Jennifer N. Serventi, Martin Glas
フォーマット:	論文
言語:	英語
出版事項:	Frontiers Media S.A. 2020-07-01
主題:	glioblastoma safety skin management Tumor Treating Fields TTFields Optune
オンライン･アクセス:	https://www.frontiersin.org/article/10.3389/fonc.2020.01045/full